{"protocolSection":{"identificationModule":{"nctId":"NCT05630859","orgStudyIdInfo":{"id":"216156"},"secondaryIdInfos":[{"id":"2022-500883-37-00","type":"OTHER","domain":"EU CT number"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age","officialTitle":"A Phase 1/2, Observer-blind, Randomized, Placebo-controlled Multi-country Study to Assess Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age"},"statusModule":{"statusVerifiedDate":"2026-05","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-11-28","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-05-22","type":"ACTUAL"},"completionDateStruct":{"date":"2025-05-22","type":"ACTUAL"},"studyFirstSubmitDate":"2022-11-25","studyFirstSubmitQcDate":"2022-11-25","studyFirstPostDateStruct":{"date":"2022-11-30","type":"ACTUAL"},"resultsFirstSubmitDate":"2026-05-19","resultsFirstSubmitQcDate":"2026-05-19","resultsFirstPostDateStruct":{"date":"2026-06-16","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-05-19","lastUpdatePostDateStruct":{"date":"2026-06-16","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"The aim of this first time in human proof of concept (FTiH-PoC) study was to evaluate safety and reactogenicity, to demonstrate efficacy and to explore immunogenicity of GlaxoSmithKline's (GSK) Neisseria gonorrhoeae generalized modules for membrane antigens (GMMA) (NgG) investigational vaccine compared to placebo (saline).","detailedDescription":"The study included the following parts:\n\n* Phase 1 - Dose-escalation safety lead-in in healthy participants.\n* Phase 2 - Efficacy PoC in healthy participants considered at risk for gonorrhea.\n\nThe doses to be tested for efficacy would be selected based on the safety evaluation performed during the dose-escalation safety lead-in: in case more than one dose would show tolerability, the highest tolerated dose (HTD) and the dose below the highest tolerated (i.e., 2 doses) would be advanced in the efficacy PoC part of the study and compared versus placebo. In case only the lowest dose shows adequate tolerability, this would be the only dose tested in the PoC versus placebo."},"conditionsModule":{"conditions":["Sexually Transmitted Diseases"],"keywords":["Neisseria gonorrhoeae","Safety","Efficacy","Sexually transmitted infection","Healthy adults 18 to 50 years of age"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"SEQUENTIAL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","maskingDescription":"Data was collected in an observer-blind manner.","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1009,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Phase 1: Neisseria gonorrhoeae GMMA (NgG) 12.5 micrograms (µg) Group","type":"EXPERIMENTAL","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61.","interventionNames":["Biological: NgG 12.5 µg investigational vaccine"]},{"label":"Phase 1: NgG 25 µg Group","type":"EXPERIMENTAL","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61.","interventionNames":["Biological: NgG 25 µg investigational vaccine"]},{"label":"Phase 1: NgG 50 µg Group","type":"EXPERIMENTAL","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61.","interventionNames":["Biological: NgG 50 µg investigational vaccine"]},{"label":"Phase 1: Placebo Group","type":"PLACEBO_COMPARATOR","description":"Participants received 2 doses of placebo on Day 1 and Day 61.","interventionNames":["Combination Product: Placebo"]},{"label":"Phase 2: NgG Highest tolerated dose (HTD; 50 µg) Group","type":"EXPERIMENTAL","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1.","interventionNames":["Biological: NgG 50 µg investigational vaccine"]},{"label":"Phase 2: NgG dose below HTD (bHTD; 25 µg) Group","type":"EXPERIMENTAL","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1.","interventionNames":["Biological: NgG 25 µg investigational vaccine"]},{"label":"Phase 2: Placebo Group","type":"PLACEBO_COMPARATOR","description":"Participants received 2 doses of placebo on Day 1 and Day 61.","interventionNames":["Combination Product: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"NgG 12.5 µg investigational vaccine","description":"2 doses of NgG 12.5 µg investigational vaccine administered intramuscularly.","armGroupLabels":["Phase 1: Neisseria gonorrhoeae GMMA (NgG) 12.5 micrograms (µg) Group"]},{"type":"BIOLOGICAL","name":"NgG 25 µg investigational vaccine","description":"2 doses of NgG 25 µg investigational vaccine administered intramuscularly.","armGroupLabels":["Phase 1: NgG 25 µg Group","Phase 2: NgG dose below HTD (bHTD; 25 µg) Group"]},{"type":"BIOLOGICAL","name":"NgG 50 µg investigational vaccine","description":"2 doses of NgG 50 µg investigational vaccine administered intramuscularly.","armGroupLabels":["Phase 1: NgG 50 µg Group","Phase 2: NgG Highest tolerated dose (HTD; 50 µg) Group"]},{"type":"COMBINATION_PRODUCT","name":"Placebo","description":"2 doses of placebo administered intramuscularly.","armGroupLabels":["Phase 1: Placebo Group","Phase 2: Placebo Group"],"otherNames":["Sodium chloride (NaCl)"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Phase 1: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 7"},{"measure":"Phase 1: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 67"},{"measure":"Phase 1: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 7"},{"measure":"Phase 1: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 67"},{"measure":"Phase 1: Number of Participants Reporting Any Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 30"},{"measure":"Phase 1: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 90"},{"measure":"Phase 1: Number of Participants Reporting Any Serious Adverse Events (SAEs) and AEs Leading to Withdrawal","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, abnormal pregnancy outcome or any other situation as determined by the investigator. An AE is any untoward medical occurrence (an unfavourable/unintended sign - including an abnormal laboratory finding), symptom, or disease (new or exacerbated) in a clinical study participant that is temporally associated with the study intervention. The AE may or may not be considered related to the study intervention. A participant is considered to have withdrawn from the study if no new study procedure has been performed or no new information has been collected for them since the date of withdrawal/last contact. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 after the first dose to Day 241"},{"measure":"Phase 1: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values","description":"The safety laboratory data included haematological parameters \\[hemoglobin, lymphocytes, platelets, neutrophils, and white blood cells (WBC)\\] and biochemical parameters (Alanine Aminotransferase \\[ALT\\], Aspartate Aminotransferase \\[AST\\], Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 haematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8 compared to baseline (Day 1)"},{"measure":"Phase 1: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"At Day 68 compared to baseline (Day 61)"},{"measure":"Phase 2: Incidence Rate of Confirmed Gonorrhea Cases","description":"Incidence of first confirmed gonorrhea cases by positive Nucleic Acid Amplification Test (NAAT) at the anorectal and/or urogenital location were evaluated. The incidence rate (y/PT) of confirmed gonorrhea cases, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)"},{"measure":"Phase 2: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 7"},{"measure":"Phase 2: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 67"},{"measure":"Phase 2: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 7"},{"measure":"Phase 2: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 67"},{"measure":"Phase 2: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 to Day 30"},{"measure":"Phase 2: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 61 to Day 90"},{"measure":"Phase 2: Number of Participants Reporting Any SAEs and AEs Leading to Withdrawal","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, abnormal pregnancy outcome or any other situation as determined by the investigator. An AE is any untoward medical occurrence (an unfavourable/unintended sign - including an abnormal laboratory finding), symptom, or disease (new or exacerbated) in a clinical study participant that is temporally associated with the study intervention. The AE may or may not be considered related to the study intervention. A participant is considered to have withdrawn from the study if no new study procedure has been performed or no new information has been collected for them since the date of withdrawal/last contact. Any = occurrence of the event regardless of intensity grade.","timeFrame":"From Day 1 after the first dose to Day 451"},{"measure":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values in HIV Negative (HIV-) Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8 compared to baseline (Day 1)"},{"measure":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values for HIV Positive (HIV+) Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, absolute lymphocyte count, platelets, absolute neutrophil count, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"At Day 8 compared to baseline (Day 1)"},{"measure":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values for HIV- Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 haematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"At Day 68 compared to baseline (Day 61)"},{"measure":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values HIV+ Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, absolute lymphocyte count, platelets, absolute neutrophil count, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"At Day 68 compared to baseline (Day 61)"}],"secondaryOutcomes":[{"measure":"Phase 2: Incidence Rates of Confirmed Gonorrhea Cases With and Without Chlamydia Trachomatis Co-infection","description":"Confirmed gonorrhea cases by positive NAAT with and without chlamydia trachomatis co-infection at the pharyngeal and/or anorectal and/or urogenital location are reported. The incidence rate (y/PT) of confirmed gonorrhea cases with and without Chlamydia Trachomatis co-infection, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases with and without Chlamydia Trachomatis co-infection (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)"},{"measure":"Phase 2: Incidence Rates of Symptomatic and Confirmed Gonorrhea Cases","description":"Symptomatic gonorrhea cases which were later confirmed gonorrhea cases are reported. Symptomatic gonorrhea cases are defined as participants with symptoms suggestive of gonorrhea at the infected anatomical site which were later confirmed by a positive NAAT at the anorectal and/or urogenital location. The incidence rate (y/PT) of confirmed gonorrhea cases, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nInclusion criteria for the dose-escalation safety lead-in part\n\n* Participants, who, in the opinion of the investigator, can and will comply with the requirements of the protocol.\n* Written or witnessed/thumb printed informed consent obtained from the participant prior to performance of any study-specific procedure.\n* Healthy participants as established by medical history, clinical examination, and laboratory assessment.\n* A participant between and including 18 and 50 years of age at the time of informed consent.\n* Female participants of non-childbearing potential may be enrolled in the study.\n* Female participants of childbearing potential may be enrolled in the study if the participant:\n\n  * has practiced adequate contraception for 1 month prior to study intervention administration, and\n  * has a negative pregnancy test on the day of study intervention administration, and\n  * has agreed to continue adequate contraception during the entire treatment period and for 1 month after completion of the study intervention administration series.\n\nInclusion criteria for the efficacy PoC part\n\n* Participants, who, in the opinion of the investigator, can and will comply with the requirements of the protocol.\n* Written or witnessed/thumb printed informed consent obtained from the participant prior to performance of any study-specific procedure.\n* Healthy participants as established by:\n\n  * For the 2 intensive safety monitoring subsets (i.e., first 30 HIV negative subjects per group followed by first 8 HIV positive subjects per group): medical history, clinical examination, and laboratory assessment.\n  * For all the remaining participants: medical history, clinical examination.\n* At risk for gonococcus infections based on sexual behavioral characteristics: this may include men having sex with men, pre-exposure prophylaxis for HIV users, individuals who engage in transactional sex participants with current or past STI diagnosis, participants at time of STI screening or seeking other STI services.\n* A participant between and including 18 and 50 years of age at the time of informed consent. Transgender men and women, and other gender non-conforming people who identify themselves as neither men nor women may be enrolled into the study, based on their risk factors. For the purpose of this study, they will be followed up according to their biological sex (sex at birth), sexual orientation, and genital/sexual anatomy\n* Participants of non-childbearing potential may be enrolled in the study. This includes transmen that have not undergone gender affirming surgery of their genitals.\n* Participants of childbearing potential may be enrolled in the study if the participant:\n\n  * has practiced adequate contraception for 1 month prior to study intervention administration, and\n  * has a negative pregnancy test on the day of study intervention administration, and\n  * has agreed to continue adequate contraception during the entire treatment period and for 1 month after completion of the study intervention administration series.\n\nExclusion criteria:\n\n1. Medical conditions Dose-escalation safety lead-in part\n\n   * Any clinically significant biochemical laboratory abnormality.\n   * Any other clinical condition as determined by the investigator, that may increase participant's risk due to study participation.\n   * History of any reaction/hypersensitivity likely to be exacerbated by any component of the study intervention.\n   * Confirmed or suspected immunosuppressive/immunodeficient condition, based on medical history and physical examination.\n   * Hypersensitivity to latex.\n   * Acute/chronic clinically significant pulmonary, cardiovascular, hepatic/renal functional abnormality, as determined by physical examination/laboratory tests.\n   * Uncontrolled neurological disorders or seizures.\n   * History of invasive meningococcal disease. Efficacy PoC part: HIV negative intensive safety monitoring, HIV negative full enrollment and for all remaining participants\n   * Persons under guardianship or trusteeship.\n   * Persons deprived of liberty.\n   * Gonococcal infection identified within 14 days prior to randomization.\n   * Any other clinical condition as determined by the investigator, that may increase participant's risk due to study participation.\n   * History of severe allergic reactions and/anaphylaxis, or any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention(s).\n   * Bleeding diathesis / any other condition that would contraindicate intramuscular administration.\n   * Confirmed or suspected immunosuppressive/immunodeficient condition, based on medical history and physical examination.\n   * Known seropositivity for HIV infection, regardless of viremia and CD4 cell count\n   * Hypersensitivity to latex.\n   * Acute/chronic clinically significant pulmonary, cardiovascular, hepatic/renal functional abnormality, as determined by physical examination/laboratory tests.\n   * Recurrent history/uncontrolled neurological disorders or seizures.\n   * History of invasive meningococcal disease.\n\n   The exclusion criteria depicted above, and the following exclusions criterion applies only for the HIV positive participants (intensive safety monitoring subset and full enrollment of HIV positive participants):\n\n   Seropositivity for HIV infection if:\n   * CD4 cell count \\< 350 cells/mm3 in the last 6 months\n   * viral load \\> 50cp/ml in the last 6 months\n   * participant is not on antiretroviral therapy (ART) for \\> 3 months or has switched from a different ART in the last 3 months.\n\n   For both Intensive safety monitoring subset (first 30 HIV negative subjects per group and first 8 HIV positive subjects per group) these criteria apply:\n\n   Any clinically significant hematological/biochemical laboratory abnormality.\n2. Prior/Concomitant therapy Applicable for both the dose-escalation safety lead-in part and the PoC part\n\n   * Use of any investigational/non-registered product other than the study intervention(s) within 30 days before the first dose/planned use during the study period.\n   * Previous and planned vaccination with an OMV based Neisseria meningitidis group B vaccine (e.g., Bexsero, MeNZB vaccine or MenBvac at any time prior to first dose and during the entire study period.\n   * Planned administration/administration of a vaccine not specified in study protocol within 15 days before the first dose and ending 15 days after the last dose of vaccine administration.\n   * Administration of long-acting immune-modifying drugs during the period starting 6 months prior to the first dose of study intervention/planned administration at any time during the study period.\n   * Administration of immunoglobulins /any blood products/plasma derivatives during the period starting 3 months before the administration of the first dose of study intervention/planned administration during the study period.\n   * Chronic administration (more than 14 days in total) of immunosuppressants/other immune-modifying drugs during the period starting 3 months prior to the first study intervention dose(s). For corticosteroids, this will mean prednisone equivalent ≥20 mg/day for adult participants/ ≥0.5 mg/kg/day. Inhaled and topical steroids are allowed.\n\n   The following criterion applies only for the PoC part:\n\n   • Chronic/long-term use of systemic antibiotics with an activity against Neisseria gonorrhoeae.\n3. Prior/Concurrent clinical study experience applicable for both dose-escalation safety lead-in part and the PoC part Concurrently participating in another clinical study, at any time during the study period, in which the participant has been/will be exposed to an investigational/a non-investigational intervention.\n4. Other exclusions applicable for both dose-escalation safety leading part and the PoC part\n\n   * Pregnant/lactating female.\n   * Female planning to become pregnant/to discontinue contraceptive precautions before 1 month after completion of the study intervention administration series.\n   * Any study personnel/their immediate dependents, family/household members.\n   * Lifestyle consideration that may interfere with the conduct of the study/pose additional risks to the rights and wellbeing of participants.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"GSK Investigational Site","city":"Washington D.C.","state":"District of Columbia","zip":"20009","country":"United States","geoPoint":{"lat":38.89511,"lon":-77.03637}},{"facility":"GSK Investigational Site","city":"Lenexa","state":"Kansas","zip":"66219","country":"United States","geoPoint":{"lat":38.95362,"lon":-94.73357}},{"facility":"GSK Investigational Site","city":"Boston","state":"Massachusetts","zip":"02215","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"GSK Investigational Site","city":"Springfield","state":"Missouri","zip":"65802","country":"United States","geoPoint":{"lat":37.21533,"lon":-93.29824}},{"facility":"GSK Investigational Site","city":"The Bronx","state":"New York","zip":"10467","country":"United States","geoPoint":{"lat":40.84985,"lon":-73.86641}},{"facility":"GSK Investigational Site","city":"Pittsburgh","state":"Pennsylvania","zip":"48202","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"GSK Investigational Site","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"GSK Investigational Site","city":"Salvador","zip":"41680-020","country":"Brazil","geoPoint":{"lat":-12.97563,"lon":-38.49096}},{"facility":"GSK Investigational Site","city":"Lyon","zip":"69004","country":"France","geoPoint":{"lat":45.74906,"lon":4.84789}},{"facility":"GSK Investigational Site","city":"Paris","zip":"75475","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"GSK Investigational Site","city":"Pierre-Bénite","zip":"69495","country":"France","geoPoint":{"lat":45.70359,"lon":4.82424}},{"facility":"GSK Investigational Site","city":"Bochum","zip":"44787","country":"Germany","geoPoint":{"lat":51.48165,"lon":7.21648}},{"facility":"GSK Investigational Site","city":"Frankfurt","zip":"60596","country":"Germany","geoPoint":{"lat":49.68333,"lon":10.53333}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"20146","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Manila","zip":"1000","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"GSK Investigational Site","city":"Johannesburg","zip":"2001","country":"South Africa","geoPoint":{"lat":-26.20227,"lon":28.04363}},{"facility":"GSK Investigational Site","city":"Soweto","zip":"2013","country":"South Africa","geoPoint":{"lat":-26.26781,"lon":27.85849}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08015","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28006","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46026","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"London","zip":"SW10 9NH","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"GSK Investigational Site","city":"London","zip":"WC1E 6JB","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"IPD for this study will be made available via the Clinical Study Data Request site.","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"IPD will be made available within 6 months of publishing the results of the primary endpoints, a key secondary endpoints and safety data of the study.","accessCriteria":"Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months."}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Phase 1 Placebo group: Enrollment in the Phase 1 portion of the study proceeded stepwise to allow three increasing dosages of the candidate vaccine to be tested against placebo. In this record we present the pooled Phase 1 placebo analysis group, which includes all participants who received placebo during Phase 1.","recruitmentDetails":"A total of 1009 participants were included in the enrolled set, out of which only 1004 were included in the exposed set and started the study. The study was conducted in 2 phases: Phase 1 was the Dose-escalation safety lead-in (SLI) phase and Phase 2 was the Efficacy Proof of Concept (PoC) phase.","groups":[{"id":"FG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"FG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"FG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"FG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."},{"id":"FG004","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"FG005","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"FG006","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"6"},{"groupId":"FG002","numSubjects":"6"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"329"},{"groupId":"FG005","numSubjects":"327"},{"groupId":"FG006","numSubjects":"324"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"6"},{"groupId":"FG002","numSubjects":"6"},{"groupId":"FG003","numSubjects":"5"},{"groupId":"FG004","numSubjects":"311"},{"groupId":"FG005","numSubjects":"304"},{"groupId":"FG006","numSubjects":"304"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"18"},{"groupId":"FG005","numSubjects":"23"},{"groupId":"FG006","numSubjects":"20"}]}],"dropWithdraws":[{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"7"},{"groupId":"FG006","numSubjects":"8"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"8"},{"groupId":"FG005","numSubjects":"6"},{"groupId":"FG006","numSubjects":"6"}]},{"type":"Migrated / Moved from the study area","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"5"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"BG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"BG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"BG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."},{"id":"BG004","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"BG005","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"BG006","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."},{"id":"BG007","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"329"},{"groupId":"BG005","value":"327"},{"groupId":"BG006","value":"324"},{"groupId":"BG007","value":"1004"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"YEARS","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"37.2","spread":"9.9"},{"groupId":"BG001","value":"39.0","spread":"5.5"},{"groupId":"BG002","value":"41.3","spread":"8.3"},{"groupId":"BG003","value":"36.7","spread":"10.3"},{"groupId":"BG004","value":"33.8","spread":"7.5"},{"groupId":"BG005","value":"34.4","spread":"7.7"},{"groupId":"BG006","value":"33.9","spread":"7.9"},{"groupId":"BG007","value":"34.1","spread":"7.7"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"69"},{"groupId":"BG005","value":"70"},{"groupId":"BG006","value":"65"},{"groupId":"BG007","value":"215"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"260"},{"groupId":"BG005","value":"257"},{"groupId":"BG006","value":"259"},{"groupId":"BG007","value":"789"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"70"},{"groupId":"BG005","value":"72"},{"groupId":"BG006","value":"73"},{"groupId":"BG007","value":"222"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"220"},{"groupId":"BG005","value":"218"},{"groupId":"BG006","value":"217"},{"groupId":"BG007","value":"670"}]},{"title":"Multiple","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"4"}]},{"title":"Not reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"12"}]},{"title":"Unknown","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"6"},{"groupId":"BG007","value":"17"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"23"},{"groupId":"BG005","value":"23"},{"groupId":"BG006","value":"24"},{"groupId":"BG007","value":"70"}]},{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"3"},{"groupId":"BG007","value":"9"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set which includes all participants who received at least one dose of the study intervention and had solicited safety data available at the specified duration. Only participants from Phase 1 groups with solicited administration site events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 7","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}],"classes":[{"title":"Pain","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythema","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 1 groups with solicited administration site events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 67","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"}]}],"classes":[{"title":"Pain","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythema","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 1 groups with solicited systemic events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 7","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}],"classes":[{"title":"Headache","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]}]},{"title":"Myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]}]},{"title":"Arthralgia","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Fever","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 1 groups with solicited systemic events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 67","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"}]}],"classes":[{"title":"Headache","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Arthralgia","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Fever","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Unsolicited Safety Set which includes all participants who received at least one dose of the study intervention and had unsolicited safety data available at the specified duration. Only participants from Phase 1 groups with unsolicited AEs data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 30","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Unsolicited Safety Set. Only participants from Phase 1 groups with unsolicited AEs data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 90","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants Reporting Any Serious Adverse Events (SAEs) and AEs Leading to Withdrawal","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, abnormal pregnancy outcome or any other situation as determined by the investigator. An AE is any untoward medical occurrence (an unfavourable/unintended sign - including an abnormal laboratory finding), symptom, or disease (new or exacerbated) in a clinical study participant that is temporally associated with the study intervention. The AE may or may not be considered related to the study intervention. A participant is considered to have withdrawn from the study if no new study procedure has been performed or no new information has been collected for them since the date of withdrawal/last contact. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Exposed set which includes all participants who received at least one dose of the study intervention and had post-vaccination data available at the specified duration. Only participants from Phase 1 groups with SAEs and AEs leading to withdrawal data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 after the first dose to Day 241","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}],"classes":[{"title":"SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AEs leading to withdrawal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values","description":"The safety laboratory data included haematological parameters \\[hemoglobin, lymphocytes, platelets, neutrophils, and white blood cells (WBC)\\] and biochemical parameters (Alanine Aminotransferase \\[ALT\\], Aspartate Aminotransferase \\[AST\\], Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 haematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"Analysis was performed on the Exposed set. Only participants from Phase 1 groups with haematological and biochemical laboratory parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8 compared to baseline (Day 1)","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"6"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"}]}]},{"title":"Creatinine, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"}]}]},{"title":"Hemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 1: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"Analysis was performed on the Exposed set. Only participants from Phase 1 groups with haematological and biochemical laboratory parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 68 compared to baseline (Day 61)","groups":[{"id":"OG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61."},{"id":"OG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"}]}],"classes":[{"title":"ALT, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Blood Urea Nitrogen, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Creatinine, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"2"}]}]},{"title":"Creatinine, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Creatinine, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Creatinine, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Hemoglobin, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hemoglobin, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"4"}]}]},{"title":"Hemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Lymphocytes, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Neutrophils, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Incidence Rate of Confirmed Gonorrhea Cases","description":"Incidence of first confirmed gonorrhea cases by positive Nucleic Acid Amplification Test (NAAT) at the anorectal and/or urogenital location were evaluated. The incidence rate (y/PT) of confirmed gonorrhea cases, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","populationDescription":"Analysis was performed on the Modified Full Analysis Efficacy Set (mFAS) which includes all participants who received full study intervention (2 doses) and had post-vaccination efficacy data available at the specified duration. Only participants from Phase 2 groups with confirmed gonorrhea cases data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Cases per 100 person-years","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"319"},{"groupId":"OG001","value":"318"},{"groupId":"OG002","value":"316"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.94"},{"groupId":"OG001","value":"26.64"},{"groupId":"OG002","value":"29.90"}]}]}],"analyses":[{"groupIds":["OG000","OG002"],"groupDescription":"To demonstrate vaccine efficacy (VE) in the prevention of gonorrhea cases between Phase 2: NgG HTD group and Phase 2: placebo group","nonInferiorityType":"OTHER","nonInferiorityComment":"Efficacy was to be demonstrated if the lower limit of the 2-sided 85% confidence interval (CI) for the VE is above 0 between the Phase 2: NgG Highest tolerated dose (HTD) group compared to the Phase 2: Placebo group.","paramType":"VE","paramValue":"9.89","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-16.69","ciUpperLimit":"30.46","estimateComment":"VE= \\[(1 - Incidence Rate Ratio (IRR)) x 100\\]. IRR=the ratio between incidence rate (IR) of confirmed gonorrhea cases in the investigational group (HTD) compared to the placebo group."},{"groupIds":["OG001","OG002"],"groupDescription":"To demonstrate VE in the prevention of gonorrhea cases between Phase 2: NgG below HTD (bHTD) group and Phase 2: placebo group","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for the bHTD group were descriptive. Formal statistical testing was not performed as the primary efficacy hypothesis for the HTD group could not be rejected.","paramType":"VE","paramValue":"10.90","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-15.63","ciUpperLimit":"31.40","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of confirmed gonorrhea cases in the investigational group (bHTD) compared to the placebo group."}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 2 groups with solicited administration site events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 7","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"327"},{"groupId":"OG001","value":"325"},{"groupId":"OG002","value":"320"}]}],"classes":[{"title":"Pain","categories":[{"measurements":[{"groupId":"OG000","value":"274"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"50"}]}]},{"title":"Erythema","categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"4"}]}]},{"title":"Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"2"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Solicited Administration Site Events","description":"Assessed solicited administration site events included injection site pain, erythema (redness), and swelling. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 2 groups with solicited administration site events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 67","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"302"},{"groupId":"OG001","value":"303"},{"groupId":"OG002","value":"286"}]}],"classes":[{"title":"Pain","categories":[{"measurements":[{"groupId":"OG000","value":"247"},{"groupId":"OG001","value":"240"},{"groupId":"OG002","value":"41"}]}]},{"title":"Erythema","categories":[{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"2"}]}]},{"title":"Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral cavity. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 2 groups with solicited systemic events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 7","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"327"},{"groupId":"OG001","value":"325"},{"groupId":"OG002","value":"320"}]}],"classes":[{"title":"Headache","categories":[{"measurements":[{"groupId":"OG000","value":"113"},{"groupId":"OG001","value":"108"},{"groupId":"OG002","value":"88"}]}]},{"title":"Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"180"},{"groupId":"OG001","value":"171"},{"groupId":"OG002","value":"111"}]}]},{"title":"Myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"187"},{"groupId":"OG001","value":"185"},{"groupId":"OG002","value":"47"}]}]},{"title":"Arthralgia","categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"57"},{"groupId":"OG002","value":"20"}]}]},{"title":"Fever","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"7"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Solicited Systemic Events","description":"Assessed solicited systemic events included headache, fatigue (tiredness), myalgia (muscle pain), arthralgia (joint pain), and fever (pyrexia). Fever is defined as body temperature \\>=38ºC; preferred location for measuring the temperature is oral. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Solicited Safety Set. Only participants from Phase 2 groups with solicited systemic events data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 67","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"302"},{"groupId":"OG001","value":"303"},{"groupId":"OG002","value":"286"}]}],"classes":[{"title":"Headache","categories":[{"measurements":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"83"},{"groupId":"OG002","value":"53"}]}]},{"title":"Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"161"},{"groupId":"OG001","value":"155"},{"groupId":"OG002","value":"75"}]}]},{"title":"Myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"163"},{"groupId":"OG001","value":"147"},{"groupId":"OG002","value":"20"}]}]},{"title":"Arthralgia","categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"12"}]}]},{"title":"Fever","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"9"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Unsolicited Safety Set. Only participants from Phase 2 groups with unsolicited AEs data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 30","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"329"},{"groupId":"OG001","value":"327"},{"groupId":"OG002","value":"324"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"66"},{"groupId":"OG002","value":"67"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any Unsolicited AEs","description":"An unsolicited AE is an AE that is either not included in the list of solicited events or can be included in the list of solicited events but with an onset outside the specified period of follow-up for solicited events. Unsolicited AEs include both serious and non-serious AEs. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Unsolicited Safety Set. Only participants from Phase 2 groups with unsolicited AEs data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 61 to Day 90","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"322"},{"groupId":"OG001","value":"318"},{"groupId":"OG002","value":"318"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"73"},{"groupId":"OG002","value":"64"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants Reporting Any SAEs and AEs Leading to Withdrawal","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, abnormal pregnancy outcome or any other situation as determined by the investigator. An AE is any untoward medical occurrence (an unfavourable/unintended sign - including an abnormal laboratory finding), symptom, or disease (new or exacerbated) in a clinical study participant that is temporally associated with the study intervention. The AE may or may not be considered related to the study intervention. A participant is considered to have withdrawn from the study if no new study procedure has been performed or no new information has been collected for them since the date of withdrawal/last contact. Any = occurrence of the event regardless of intensity grade.","populationDescription":"Analysis was performed on the Exposed set. Only participants from Phase 2 groups with SAEs and AEs leading to withdrawal data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 after the first dose to Day 451","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"329"},{"groupId":"OG001","value":"327"},{"groupId":"OG002","value":"324"}]}],"classes":[{"title":"SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"3"}]}]},{"title":"AEs leading to withdrawal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values in HIV Negative (HIV-) Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"Analysis was performed on the HIV negative subset of the Exposed set which includes all HIV negative participants who received at least one dose of the study intervention and had post-vaccination data available at the specified timepoint. Only participants from Phase 2 groups with haematological and biochemical parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8 compared to baseline (Day 1)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"30"}]}],"classes":[{"title":"ALT, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"29"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"30"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"29"}]}]},{"title":"Blood Urea Nitrogen, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"}]}]},{"title":"Hemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Hemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"25"}]}]},{"title":"Hemoglobin, Below, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"30"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"27"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"29"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"26"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}]}]},{"title":"Creatinine, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values for HIV Positive (HIV+) Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, absolute lymphocyte count, platelets, absolute neutrophil count, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 1 (baseline) and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"Analysis was performed on the HIV positive subset of the Exposed set which includes all HIV positive participants who received at least one dose of the study intervention and had post-vaccination data available at the specified timepoint. Only participants from Phase 2 groups with haematological and biochemical parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8 compared to baseline (Day 1)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"classes":[{"title":"ALT, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"5"}]}]},{"title":"ALT, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"5"}]}]},{"title":"AST, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Blood Urea Nitrogen, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"5"}]}]},{"title":"Blood Urea Nitrogen, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Blood Urea Nitrogen, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"5"}]}]},{"title":"Creatinine, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Lymphocyte Count, Unknown, Unknown","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"Absolute Lymphocyte Count, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}]},{"title":"Absolute Lymphocyte Count, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Absolute Neutrophil Count, Unknown, Unknown","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"Absolute Neutrophil Count, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Neutrophil Count, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}]},{"title":"Hemoglobin, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hemoglobin, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"}]}]},{"title":"Hemoglobin, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}]},{"title":"Platelets, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]}]}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values for HIV- Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, lymphocytes, platelets, neutrophils, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 haematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"Analysis was performed on the HIV negative subset of the Exposed set which includes all HIV negative participants who received at least one dose of the study intervention and had post-vaccination data available at the specified timepoint. Only participants from Phase 2 groups with haematological and biochemical parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 68 compared to baseline (Day 61)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"classes":[{"title":"ALT, Above, Unknown","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"29"}]}]},{"title":"ALT, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Unknown","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"28"}]}]},{"title":"AST, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Blood Urea Nitrogen, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Blood Urea Nitrogen, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"27"}]}]},{"title":"Creatinine, Unknown, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"26"}]}]},{"title":"Creatinine, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hemoglobin, Unknown, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}]},{"title":"Hemoglobin, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Hemoglobin, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hemoglobin, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"24"}]}]},{"title":"Hemoglobin, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Lymphocytes, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"29"}]}]},{"title":"Lymphocytes, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"Neutrophils, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"26"}]}]},{"title":"Neutrophils, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"28"}]}]},{"title":"Platelets, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Unknown, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"WBC, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Unknown, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"27"}]}]},{"title":"WBC, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"SECONDARY","title":"Phase 2: Incidence Rates of Confirmed Gonorrhea Cases With and Without Chlamydia Trachomatis Co-infection","description":"Confirmed gonorrhea cases by positive NAAT with and without chlamydia trachomatis co-infection at the pharyngeal and/or anorectal and/or urogenital location are reported. The incidence rate (y/PT) of confirmed gonorrhea cases with and without Chlamydia Trachomatis co-infection, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases with and without Chlamydia Trachomatis co-infection (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","populationDescription":"Analysis was performed on the mFAS. Only participants from Phase 2 groups with confirmed gonorrhea cases with and without Chlamydia Trachomatis data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Cases per 100 person-years","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"319"},{"groupId":"OG001","value":"318"},{"groupId":"OG002","value":"316"}]}],"classes":[{"title":"Gonorrhea with co-infection","categories":[{"measurements":[{"groupId":"OG000","value":"3.46"},{"groupId":"OG001","value":"4.76"},{"groupId":"OG002","value":"5.67"}]}]},{"title":"Gonorrhea without co-infection","categories":[{"measurements":[{"groupId":"OG000","value":"37.60"},{"groupId":"OG001","value":"32.02"},{"groupId":"OG002","value":"37.54"}]}]}],"analyses":[{"groupIds":["OG000","OG002"],"groupDescription":"To demonstrate VE in prevention of gonorrhea cases with Chlamydia Trachomatis co-infection between Phase 2: NgG HTD group and Phase 2: placebo group.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"39.07","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-26.55","ciUpperLimit":"71.62","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of confirmed gonorrhea cases with Chlamydia trachomatis co-infection in the investigational group (HTD) compared to the placebo group."},{"groupIds":["OG001","OG002"],"groupDescription":"To demonstrate VE in prevention of gonorrhea cases with Chlamydia Trachomatis co-infection between phase 2: NgG bHTD group and phase 2: placebo groups.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"16.12","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-63.71","ciUpperLimit":"57.42","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of confirmed gonorrhea cases with Chlamydia trachomatis co-infection in the investigational group (bHTD) compared to the placebo group."},{"groupIds":["OG000","OG002"],"groupDescription":"To demonstrate VE in prevention of gonorrhea cases without Chlamydia trachomatis co-infection between phase 2: NgG HTD group and phase 2: placebo groups.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"-0.17","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-26.12","ciUpperLimit":"20.44","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of confirmed gonorrhea cases without Chlamydia trachomatis co-infection in the investigational group (HTD) compared to the placebo group."},{"groupIds":["OG001","OG002"],"groupDescription":"To demonstrate VE in prevention of gonorrhea cases without Chlamydia trachomatis co-infection between phase 2: NgG bHTD group and phase 2: placebo groups.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"14.70","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-8.47","ciUpperLimit":"32.98","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of confirmed gonorrhea cases without Chlamydia trachomatis co-infection in the investigational group (bHTD) compared to the placebo group."}]},{"type":"SECONDARY","title":"Phase 2: Incidence Rates of Symptomatic and Confirmed Gonorrhea Cases","description":"Symptomatic gonorrhea cases which were later confirmed gonorrhea cases are reported. Symptomatic gonorrhea cases are defined as participants with symptoms suggestive of gonorrhea at the infected anatomical site which were later confirmed by a positive NAAT at the anorectal and/or urogenital location. The incidence rate (y/PT) of confirmed gonorrhea cases, expressed in terms of 100 person-years, was calculated as the number of confirmed gonorrhea cases (y) in a group, over the sum of individual person-times at risk (PT) in the same group, and multiplied by 100.","populationDescription":"Analysis was performed on the mFAS. Only participants from Phase 2 groups with symptomatic and confirmed gonorrhea cases data available for the specified analysis at the specified duration were included in this outcome measure.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Cases per 100 person-years","timeFrame":"From 1 month post-Dose 2 (Day 91) to 13 months post-Dose 2 (Day 451)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"319"},{"groupId":"OG001","value":"318"},{"groupId":"OG002","value":"316"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.54"},{"groupId":"OG001","value":"9.55"},{"groupId":"OG002","value":"5.88"}]}]}],"analyses":[{"groupIds":["OG000","OG002"],"groupDescription":"To demonstrate VE in prevention of symptomatic and confirmed gonorrhea cases between phase 2: NgG HTD group and phase 2: placebo groups.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"-45.28","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-146.1","ciUpperLimit":"13.25","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of symptomatic and confirmed gonorrhea cases in the investigational group (HTD) compared to the placebo group."},{"groupIds":["OG001","OG002"],"groupDescription":"To demonstrate VE in prevention of symptomatic and confirmed gonorrhea cases between phase 2: NgG bHTD group and phase 2: placebo groups.","nonInferiorityType":"OTHER","nonInferiorityComment":"The statistical analyses performed for this study objective were descriptive and no success criteria were defined for this statistical analysis.","paramType":"VE","paramValue":"-62.42","ciPctValue":"85","ciNumSides":"TWO_SIDED","ciLowerLimit":"-172.8","ciUpperLimit":"1.99","estimateComment":"VE= \\[(1 - IRR) x 100\\]. IRR=the ratio between IR of symptomatic and confirmed gonorrhea cases in the investigational group (bHTD) compared to the placebo group."}]},{"type":"PRIMARY","title":"Phase 2: Number of Participants With Change From Baseline in Haematological and Biochemical Laboratory Values HIV+ Subset","description":"The safety laboratory data included haematological parameters (hemoglobin, absolute lymphocyte count, platelets, absolute neutrophil count, and WBC) and biochemical parameters (ALT, AST, Blood Urea Nitrogen and Creatinine). Categories reported when comparing Day 61 (baseline) and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at baseline\\>, \\<range at timing\\> (e.g. ALT, Within, Within). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Unknown = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"Analysis was performed on the HIV positive subset of the Exposed set which includes all HIV positive participants who received at least one dose of the study intervention and had post-vaccination data available at the specified timepoint. Only participants from Phase 2 groups with haematological and biochemical parameters data available for the specified analysis at the specified timepoint were included in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 68 compared to baseline (Day 61)","groups":[{"id":"OG000","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1."},{"id":"OG001","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1."},{"id":"OG002","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"}]}],"classes":[{"title":"ALT, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Blood Urea Nitrogen, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"}]}]},{"title":"Blood Urea Nitrogen, Unknown, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Unknown, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Within, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"}]}]},{"title":"Creatinine, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Lymphocyte Count, Unknown, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Absolute Lymphocyte Count, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Lymphocyte Count, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Lymphocyte Count, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"}]}]},{"title":"Absolute Lymphocyte Count, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Neutrophil Count, Unknown, Unknown","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Absolute Neutrophil Count, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Absolute Neutrophil Count, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"}]}]},{"title":"Hemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]}]},{"title":"Hemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Unknown, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Solicited AEs: From Day 1 to Day 7 and from Day 61 to Day 67 in both phases. Unsolicited AEs: From Day 1 to Day 30 and from Day 61 to Day 90 in both phases. All-cause mortality, SAEs, AEs leading to withdrawal: From Day 1 to Day 241 in Phase 1 and from Day 1 to Day 451 in Phase 2.","description":"All events presented in the All-cause mortality, Serious Adverse Events and Other (not including Serious) Adverse Events modules are reported for the Exposed Set which includes all participants who received at least 1 dose of the study intervention.","eventGroups":[{"id":"EG000","title":"Phase 1: Neisseria Gonorrhoeae GMMA (NgG) 12.5 Micrograms (µg) Group","description":"Participants received 2 doses of NgG 12.5 µg investigational vaccine on Day 1 and Day 61.","deathsNumAffected":0,"deathsNumAtRisk":6,"seriousNumAffected":0,"seriousNumAtRisk":6,"otherNumAffected":5,"otherNumAtRisk":6},{"id":"EG001","title":"Phase 1: NgG 25 µg Group","description":"Participants received 2 doses of NgG 25 µg investigational vaccine on Day 1 and Day 61.","deathsNumAffected":0,"deathsNumAtRisk":6,"seriousNumAffected":0,"seriousNumAtRisk":6,"otherNumAffected":4,"otherNumAtRisk":6},{"id":"EG002","title":"Phase 1: NgG 50 µg Group","description":"Participants received 2 doses of NgG 50 µg investigational vaccine on Day 1 and Day 61.","deathsNumAffected":0,"deathsNumAtRisk":6,"seriousNumAffected":0,"seriousNumAtRisk":6,"otherNumAffected":6,"otherNumAtRisk":6},{"id":"EG003","title":"Phase 1: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61.","deathsNumAffected":0,"deathsNumAtRisk":6,"seriousNumAffected":0,"seriousNumAtRisk":6,"otherNumAffected":5,"otherNumAtRisk":6},{"id":"EG004","title":"Phase 2: NgG Highest Tolerated Dose (HTD; 50 µg) Group","description":"Participants received 2 doses of NgG HTD (50 µg) investigational vaccine on Day 1 and Day 61. The HTD was selected based on the safety evaluation performed in Phase 1.","deathsNumAffected":0,"deathsNumAtRisk":329,"seriousNumAffected":3,"seriousNumAtRisk":329,"otherNumAffected":303,"otherNumAtRisk":329},{"id":"EG005","title":"Phase 2: NgG Dose Below HTD (bHTD; 25 µg) Group","description":"Participants received 2 doses of NgG bHTD (25 µg) investigational vaccine on Day 1 and Day 61. The bHTD is selected based on the safety evaluation performed in Phase 1.","deathsNumAffected":0,"deathsNumAtRisk":327,"seriousNumAffected":11,"seriousNumAtRisk":327,"otherNumAffected":305,"otherNumAtRisk":327},{"id":"EG006","title":"Phase 2: Placebo Group","description":"Participants received 2 doses of placebo on Day 1 and Day 61.","deathsNumAffected":0,"deathsNumAtRisk":324,"seriousNumAffected":3,"seriousNumAtRisk":324,"otherNumAffected":232,"otherNumAtRisk":324}],"seriousEvents":[{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Anal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Food poisoning","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Toxicity to various agents","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Nose deformity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Burnout syndrome","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Conversion disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Major depression","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Lymphadenitis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Supraventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Deafness unilateral","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Ear pain","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Thyroid disorder","organSystem":"Endocrine disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Chalazion","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Conjunctivitis allergic","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Eye pain","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Periorbital swelling","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Vision blurred","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Anal fissure","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Anal skin tags","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Aphthous ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Cannabinoid hyperemesis syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Dental caries","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":5,"numAffected":5,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Haemorrhoidal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Odynophagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Oral disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Paraesthesia oral","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Tooth impacted","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Administration site erythema","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":91,"numAffected":65,"numAtRisk":329},{"groupId":"EG005","numEvents":74,"numAffected":56,"numAtRisk":327},{"groupId":"EG006","numEvents":6,"numAffected":6,"numAtRisk":324}]},{"term":"Administration site pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":4,"numAtRisk":6},{"groupId":"EG001","numEvents":8,"numAffected":4,"numAtRisk":6},{"groupId":"EG002","numEvents":11,"numAffected":6,"numAtRisk":6},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":6},{"groupId":"EG004","numEvents":521,"numAffected":289,"numAtRisk":329},{"groupId":"EG005","numEvents":515,"numAffected":292,"numAtRisk":327},{"groupId":"EG006","numEvents":91,"numAffected":75,"numAtRisk":324}]},{"term":"Administration site swelling","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":85,"numAffected":66,"numAtRisk":329},{"groupId":"EG005","numEvents":77,"numAffected":58,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":6},{"groupId":"EG003","numEvents":5,"numAffected":4,"numAtRisk":6},{"groupId":"EG004","numEvents":341,"numAffected":219,"numAtRisk":329},{"groupId":"EG005","numEvents":327,"numAffected":221,"numAtRisk":327},{"groupId":"EG006","numEvents":189,"numAffected":141,"numAtRisk":324}]},{"term":"Hyperthermia","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":6,"numAffected":6,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":324}]},{"term":"Injection site discharge","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Injection site haematoma","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Injection site pruritus","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Injection site rash","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":24,"numAffected":22,"numAtRisk":329},{"groupId":"EG005","numEvents":29,"numAffected":27,"numAtRisk":327},{"groupId":"EG006","numEvents":17,"numAffected":17,"numAtRisk":324}]},{"term":"Hypertransaminasaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Anal chlamydia infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Anorectal herpes","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Bacterial ureteritis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Balanitis candida","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Body tinea","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":4,"numAffected":4,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Bronchitis viral","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":329},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":327},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":324}]},{"term":"Campylobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Chlamydial infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":9,"numAffected":9,"numAtRisk":329},{"groupId":"EG005","numEvents":15,"numAffected":15,"numAtRisk":327},{"groupId":"EG006","numEvents":9,"numAffected":9,"numAtRisk":324}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Conjunctivitis viral","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Diarrhoea infectious","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Ear infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Enterobiasis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Fungal foot infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Fungal infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Fungal skin infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":329},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":327},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":324}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Gastrointestinal infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Genital herpes","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":324}]},{"term":"Genitourinary chlamydia infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Gingivitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"HIV infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Helicobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Herpes simplex","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Herpes simplex anorectal","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Herpes virus infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Hordeolum","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":10,"numAffected":10,"numAtRisk":329},{"groupId":"EG005","numEvents":8,"numAffected":8,"numAtRisk":327},{"groupId":"EG006","numEvents":6,"numAffected":5,"numAtRisk":324}]},{"term":"Lice infestation","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Monkeypox","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Mycoplasma genitalium infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Mycoplasma infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":10,"numAffected":10,"numAtRisk":329},{"groupId":"EG005","numEvents":9,"numAffected":9,"numAtRisk":327},{"groupId":"EG006","numEvents":7,"numAffected":6,"numAtRisk":324}]},{"term":"Onychomycosis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Oral herpes","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":327},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":324}]},{"term":"Proctitis chlamydial","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Proctitis herpes","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Pulpitis dental","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Respiratory tract infection viral","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Scabies","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Secondary syphilis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Shigella infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":4,"numAffected":3,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Syphilis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":5,"numAffected":5,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Tooth infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":14,"numAffected":13,"numAtRisk":329},{"groupId":"EG005","numEvents":11,"numAffected":10,"numAtRisk":327},{"groupId":"EG006","numEvents":6,"numAffected":6,"numAtRisk":324}]},{"term":"Urethritis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Urethritis chlamydial","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Urethritis mycoplasmal","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Viral upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Vulvovaginal candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Arthropod bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Eye contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Face injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Ligament injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Muscle rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Skin abrasion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":3,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Blood HIV RNA increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"White blood cell count decreased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":6},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG004","numEvents":114,"numAffected":88,"numAtRisk":329},{"groupId":"EG005","numEvents":103,"numAffected":73,"numAtRisk":327},{"groupId":"EG006","numEvents":32,"numAffected":32,"numAtRisk":324}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Bursitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Exostosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Joint swelling","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Muscle contracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":6},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6},{"groupId":"EG002","numEvents":5,"numAffected":4,"numAtRisk":6},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":6},{"groupId":"EG004","numEvents":350,"numAffected":224,"numAtRisk":329},{"groupId":"EG005","numEvents":334,"numAffected":214,"numAtRisk":327},{"groupId":"EG006","numEvents":67,"numAffected":63,"numAtRisk":324}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Anogenital warts","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Electric shock sensation","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":6},{"groupId":"EG004","numEvents":203,"numAffected":153,"numAtRisk":329},{"groupId":"EG005","numEvents":193,"numAffected":154,"numAtRisk":327},{"groupId":"EG006","numEvents":142,"numAffected":118,"numAtRisk":324}]},{"term":"Migraine with aura","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Tension headache","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Adjustment disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Attention deficit hyperactivity disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Mixed anxiety and depressive disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Sleep disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Stress","organSystem":"Psychiatric disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Balanoposthitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Bartholin's cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Erectile dysfunction","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Haematospermia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":324}]},{"term":"Intermenstrual bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Menstruation irregular","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Penile dermatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Testicular mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Vaginal discharge","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":324}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Catarrh","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Nasal pruritus","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Nasal septum deviation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Rhinitis allergic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Androgenetic alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":324}]},{"term":"Blister","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Intertrigo","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Photosensitivity reaction","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Rash vesicular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":324}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":329},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]},{"term":"Venous thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":6},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":329},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":327},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":324}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"GSKClinicalSupportHD@gsk.com","phone":"866-435-7343"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2024-12-03","uploadDate":"2026-05-19T11:03","filename":"Prot_000.pdf","size":2737526},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2025-01-10","uploadDate":"2026-05-19T11:03","filename":"SAP_001.pdf","size":3064080}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D012749","term":"Sexually Transmitted Diseases"}],"ancestors":[{"id":"D003141","term":"Communicable Diseases"},{"id":"D007239","term":"Infections"},{"id":"D000091662","term":"Genital Diseases"},{"id":"D000091642","term":"Urogenital Diseases"},{"id":"D020969","term":"Disease Attributes"},{"id":"D010335","term":"Pathologic Processes"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"}]},"interventionBrowseModule":{"meshes":[{"id":"D012965","term":"Sodium Chloride"}],"ancestors":[{"id":"D002712","term":"Chlorides"},{"id":"D006851","term":"Hydrochloric Acid"},{"id":"D017606","term":"Chlorine Compounds"},{"id":"D007287","term":"Inorganic Chemicals"},{"id":"D017670","term":"Sodium Compounds"}]}},"hasResults":true}